
Sanara MedTech Inc. – NASDAQ:SMTI
Sanara MedTech stock price today
Sanara MedTech stock price monthly change
Sanara MedTech stock price quarterly change
Sanara MedTech stock price yearly change
Sanara MedTech key metrics
Market Cap | 302.44M |
Enterprise value | 384.43M |
P/E | -47.29 |
EV/Sales | 6.07 |
EV/EBITDA | -74.88 |
Price/Sales | 6.19 |
Price/Book | 9.38 |
PEG ratio | -1.71 |
EPS | -0.58 |
Revenue | 68.00M |
EBITDA | -3.59M |
Income | -4.88M |
Revenue Q/Q | 19.42% |
Revenue Y/Y | 26.98% |
Profit margin | -22.6% |
Oper. margin | -28.75% |
Gross margin | 87.17% |
EBIT margin | -28.75% |
EBITDA margin | -5.28% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSanara MedTech stock price history
Sanara MedTech stock forecast
Sanara MedTech financial statements
Jun 2023 | 15.75M | -1.82M | -11.6% |
---|---|---|---|
Sep 2023 | 16.02M | -1.06M | -6.62% |
Dec 2023 | 17.68M | -237.19K | -1.34% |
Mar 2024 | 18.53M | -1.76M | -9.52% |
2025 | 88.6M | -910.68K | -1.03% |
---|
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 58278781 | 17.31M | 29.71% |
---|---|---|---|
Sep 2023 | 75474072 | 31.37M | 41.57% |
Dec 2023 | 73871149 | 29.28M | 39.64% |
Mar 2024 | 70911940 | 27.90M | 39.35% |
Jun 2023 | -1.71M | -12.94K | 506.58K |
---|---|---|---|
Sep 2023 | 1.06M | -10.11M | 9.22M |
Dec 2023 | -848.53K | -54.27K | -185.88K |
Mar 2024 | -1.59M | -65.81K | -658.79K |
Sanara MedTech alternative data
Aug 2023 | 101 |
---|---|
Sep 2023 | 101 |
Oct 2023 | 101 |
Nov 2023 | 101 |
Dec 2023 | 101 |
Jan 2024 | 101 |
Feb 2024 | 101 |
Mar 2024 | 107 |
Apr 2024 | 107 |
May 2024 | 107 |
Jun 2024 | 107 |
Jul 2024 | 107 |
Sanara MedTech other data
Period | Buy | Sel |
---|---|---|
Jun 2022 | 0 | 1820 |
Jul 2022 | 0 | 1680 |
Sep 2022 | 0 | 1000 |
Nov 2022 | 0 | 1000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | MCNEIL MICHAEL D. officer: Chief Fi.. | Common Stock | 1,000 | $6 | $6,000 | ||
Option | MCNEIL MICHAEL D. officer: Chief Fi.. | Employee Stock Option (right to buy) | 1,000 | $6 | $6,000 | ||
Sale | FLEMING ZACHARY B. officer: Chief Ex.. | Common Stock | 417 | $33 | $13,761 | ||
Sale | FLEMING ZACHARY B. officer: Chief Ex.. | Common Stock | 563 | $33 | $18,579 | ||
Sale | FLEMING ZACHARY B. officer: Chief Ex.. | Common Stock | 20 | $33.02 | $660 | ||
Sale | BOWMAN SHAWN M. officer: Pres. - .. | Common Stock | 340 | $28.56 | $9,710 | ||
Sale | BOWMAN SHAWN M. officer: Pres. - .. | Common Stock | 660 | $27.54 | $18,176 | ||
Sale | FLEMING ZACHARY B. officer: Chief Ex.. | Common Stock | 750 | $23 | $17,250 | ||
Sale | FLEMING ZACHARY B. officer: Chief Ex.. | Common Stock | 665 | $22 | $14,630 | ||
Sale | FLEMING ZACHARY B. officer: Chief Ex.. | Common Stock | 265 | $21.45 | $5,684 |
Quarter | Transcript |
---|---|
Q1 2024 14 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 26 Mar 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 14 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 15 Aug 2023 | Q2 2023 Earnings Call Transcript |
Sanara MedTech: A Promising Growth Story At An Attractive Valuation
Sanara MedTech: Surgical Sales Set To Accelerate While Post Acute Care Platform Develops
InfuSystem: Disappointing 2022 Results Lead To Bargain Prices
Sanara MedTech: A High Growth Micro Cap Disrupting The Wound And Skin Care Space
Sanara MedTech: Triple-Digit Revenue Upside In Q3, Expanding Footprint, Reaffirm Buy
Sanara MedTech: Differentiated Offering With Niche Wound Care Exposure
Sanara MedTech: Technology For Faster Healing Wounds
A Future Wound Care Compounder With Massive Upside Optionality - Sanara MedTech
Neil Cataldi From Blueprint Discusses Sanara MedTech
-
What's the price of Sanara MedTech stock today?
One share of Sanara MedTech stock can currently be purchased for approximately $30.96.
-
When is Sanara MedTech's next earnings date?
Unfortunately, Sanara MedTech's (SMTI) next earnings date is currently unknown.
-
Does Sanara MedTech pay dividends?
No, Sanara MedTech does not pay dividends.
-
How much money does Sanara MedTech make?
Sanara MedTech has a market capitalization of 302.44M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 41.77% to 64.99M US dollars.
-
What is Sanara MedTech's stock symbol?
Sanara MedTech Inc. is traded on the NASDAQ under the ticker symbol "SMTI".
-
What is Sanara MedTech's primary industry?
Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.
-
How do i buy shares of Sanara MedTech?
Shares of Sanara MedTech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Sanara MedTech's key executives?
Sanara MedTech's management team includes the following people:
- Mr. Zachary B. Fleming Chief Executive Officer(age: 50, pay: $345,410)
- Mr. Shawn M. Bowman Co-Chief Operating Officer & Pres of Wound Care(age: 50, pay: $326,430)
- Mr. Michael D. McNeil Chief Financial Officer & Corporation Sec.(age: 59, pay: $256,210)
-
How many employees does Sanara MedTech have?
As Jul 2024, Sanara MedTech employs 107 workers.
-
When Sanara MedTech went public?
Sanara MedTech Inc. is publicly traded company for more then 31 years since IPO on 7 Apr 1994.
-
What is Sanara MedTech's official website?
The official website for Sanara MedTech is sanaramedtech.com.
-
Where are Sanara MedTech's headquarters?
Sanara MedTech is headquartered at 1200 Summit Avenue, Fort Worth, TX.
-
How can i contact Sanara MedTech?
Sanara MedTech's mailing address is 1200 Summit Avenue, Fort Worth, TX and company can be reached via phone at +81 75292300.
Sanara MedTech company profile:

Sanara MedTech Inc.
sanaramedtech.comNASDAQ
107
Medical - Instruments & Supplies
Healthcare
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako's Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako's Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako's Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Fort Worth, TX 76102
CIK: 0000714256
ISIN: US79957L1008
CUSIP: 79957L100